Travere Therapeutics, Inc. (TVTX)

NASDAQ

$52.22

$+0.14

(+0.28%)

Regular Market

Travere Therapeutics, Inc. (TVTX) Live Price Chart

Last updated: ⁦2026-10-13 16:23:20⁩. Prices reflect the latest regular market data. Stock price data is sourced from Massive.

Summary

Travere Therapeutics, Inc. (TVTX) operates in the PHARMACEUTICAL PREPARATIONS sector and is listed on NASDAQ. The stock is currently priced at $52.22, with a market capitalization of $4.91B and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $22.59 to $68.73. This page covers its latest market performance, valuation, price trends and company information.

Key Market Data

Market Cap	$4.91B
Open	$51.57
Day's High	$68.73
Day's Low	$5.12
Previous Close	$52.02
Volume	476.63K
Average Volume	1.60M
P/E Ratio	--
52-Week High	$68.73
52-Week Low	$22.59
Dividend Yield	--
Earnings Date	--

Travere Therapeutics, Inc. (TVTX) Stock Price Today

Travere Therapeutics, Inc. (TVTX) is currently trading at $52.22 as of 2026-10-13 16:21:00, up 0.37% ($0.20) from the previous close of $52.02

During today's regular trading session, TVTX has traded between $5.12 and $68.73, with a trading volume of 476.63K shares. The current price is near the upper end of today's range.

Travere Therapeutics, Inc. (TVTX) 7-Day Stock Price Change

Over the past seven days, Travere Therapeutics, Inc. (TVTX) moved from $56.93 to $52.22, representing a decline of 8.28% ($4.71).

The stock traded between $51.38 and $58.77 during the period. The latest price is near the lower end of the 7-day range, indicating strong downward.

The average daily volume was 2.16 million shares, up versus the previous seven-day period, indicating higher trading activity.

TVTX 52-Week Price Position

Position in Range: 64.2%

52W Low$22.59

52W High$68.73

TVTX is currently trading at $52.22, placing it 64.2% of the way from its 52-week low of $22.59 to its 52-week high of $68.73. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.

What is Travere Therapeutics, Inc. (TVTX)?

Travere Therapeutics Inc is a biopharmaceutical company. The company is focused on identifying, developing and delivering life-changing therapies to people living with rare kidney, liver, and metabolic diseases. Its pipeline candidate, sparsentan, is an investigational product candidate in late-stage development for focal segmental glomerulosclerosis (FSGS) and IgA nephropathy (IgAN)-rare kidney disorders that often cause end-stage kidney disease. It is also advancing pegtibatinase, a novel investigational enzyme replacement therapy for the treatment of HCU, a genetic disorder caused by a deficiency in a pivotal enzyme essential to the body.

Travere Therapeutics, Inc. Information

Industry	PHARMACEUTICAL PREPARATIONS
Employees	497
Exchange	NASDAQ
Company Website	https://www.travere.com

How to Buy Travere Therapeutics, Inc. (TVTX) Stock on MEXC

Eligible investors can buy real shares of Travere Therapeutics, Inc. (TVTX) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.

Step 1: Open and Verify Your RealStocks Account

Log in to the MEXC App, go to Trade → RealStocks, and select Open Account. Complete the required account-opening and identity verification process with MEXC's partner licensed broker.

Step 2: Transfer USDT to Your RealStocks Account

Go to Wallets → RealStocks and transfer USDT from your Spot Account to your RealStocks Account. RealStocks are quoted in USD, while account funding can be completed using USDT.

Step 3: Search for TVTX and Place Your Order

Open the RealStocks trading page and search for TVTX. Select a market or limit order, enter the price and quantity as required, review the order details, and submit your order. Once filled, the corresponding real shares will be held in your RealStocks Account.

Frequently Asked Questions (FAQ)

1.What is Travere Therapeutics, Inc. (TVTX) stock price today?

Travere Therapeutics, Inc. (TVTX) is currently trading at $ 52.22, up 0.37% ($0.20) from the previous close of $ 52.02. Intraday prices update in real time during regular trading hours.

2.Is TVTX stock going up or down today?

As of 2026-10-13 16:21:00, TVTX is trading at $ 52.22, up 0.37% ($0.20) from its previous close of $ 52.02. The stock has traded between $ 5.12 and $ 68.73 during today’s regular session. Past price movements do not guarantee future results.

3.What is TVTX pre-market price?

As of 2026-10-13 16:21:00, TVTX is trading at $ 52.18 in pre-market trading, up 0.30% ($0.15) from the previous close of $ 52.02. Pre-market prices reflect trading activity before the regular session opens and may experience lower liquidity and higher volatility.

4.What is TVTX after-hours price?

As of 2026-10-13 16:21:00, TVTX is trading at $ 52.01 in after-hours trading, down 0.02% ($0.01) from the regular-session close of $ 52.02. After-hours prices may differ from the regular session’s opening price due to lower liquidity and wider bid-ask spreads.

5.Is TVTX stock trading now?

TVTX trades on the NASDAQ exchange during regular hours, Monday through Friday, 9:30 AM to 4:00 PM ET, excluding public holidays. Pre-market and after-hours trading are also available through select brokers outside these hours.

6.Where does TVTX sit relative to its 52-week high and low?

Over the past 52 weeks, TVTX has traded between a low of $ 22.59 and a high of $ 68.73. At $ 52.22, the stock is positioned 64.2% of the way from its 52-week low to its 52-week high, providing context for its current price within the one-year trading range.

7.What sector is Travere Therapeutics, Inc. in?

Travere Therapeutics, Inc. (TVTX) operates in the PHARMACEUTICAL PREPARATIONS sector. Sector classification helps investors compare it with companies exposed to similar market trends and competitive conditions.

8.What is Travere Therapeutics, Inc.'s market capitalization and where is it listed?

Travere Therapeutics, Inc. is listed on the NASDAQ exchange with a market capitalization of $ 4.91B. Market cap reflects the total market value of all outstanding shares and is commonly used to classify stocks by size.

9.How is TVTX valued in terms of P/E ratio and EPS?

TVTX trades at a P/E ratio of --, based on trailing-twelve-month EPS of $ -0.46. P/E ratio compares the stock price to earnings per share and is a common starting point for assessing valuation relative to peers.

10.Does Travere Therapeutics, Inc. pay a dividend?

Travere Therapeutics, Inc. pays an indicated annual cash dividend of $ 0.00 per share, with a current dividend yield of 0.00% based on the latest share price. Dividend policies are subject to change at the board's discretion.